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Faecal levels of zonula occludens toxin in paediatric patients with Crohn's disease and their association with the intestinal microbiota Crohn's disease, one of the major types of inflammatory bowel disease, is an inflammatory condition that can affect any area of the gastrointestinal tract. Pathogenic micro-organism(s) or dysbiosis of the intestinal microflora have been suggested to be initiators of the disease (Man et al., 2011) . Over recent years, our group has investigated the possible role of pathogenic Campylobacter concisus strains as initiators of inflammatory bowel disease (Kaakoush & Mitchell, 2012) . Based on findings related to the pathogenesis of C. concisus (Burgos-Portugal et al., 2014; Kaakoush et al., 2010 Kaakoush et al., , 2011b Man et al., 2010; Nielsen et al., 2011) , we hypothesized that C. concisus strains can be subdivided into two pathotypes, adherent and invasive C. concisus (AICC) and adherent and toxigenic C. concisus (AToCC), which are distinct from nonpathogenic strains (Kaakoush et al., 2014b) . Briefly, AICC strains possess greater ability to survive intracellularly within intestinal epithelial cells, whilst AToCC strains produce a zonula occludens toxin (ZOT) (Kaakoush et al., 2014b) . ZOT is used by virulent pathogens such as Vibrio cholerae and Neisseria meningitidis to increase tissue permeability by targeting tight junctions (Fasano et al., 1995) .
Recently, we analysed the levels of C. concisus and exotoxin 9 (a putative virulence factor associated with increased intracellular survival) in Crohn's disease patients and healthy controls, and found that Crohn's disease patients not only had higher levels of C. concisus, but also that their strains were more likely to be AICC as compared with healthy controls (Kaakoush et al., 2014a) . Given that our previous study did not examine the prevalence or abundance of AToCC in these subjects (Kaakoush et al., 2014a) , we recently determined the levels of ZOT DNA in the same subjects [30 newly diagnosed paediatric Crohn's disease patients and 30 paediatric healthy controls (Tables 1 and 2 )], and correlated these levels with the abundance of C. concisus, exotoxin 9 and other microbial taxa.
To do this, DNA was extracted from 0.22 g faeces using a QIAamp DNA Stool Mini kit and levels of ZOT DNA were quantified on a Rotor Gene 6000 real-time PCR cycler using the primers ZotF and Zot2, as previously described (Kaakoush et al., 2011a (Kaakoush et al., , 2014a . Standard curves were constructed for the ZOT PCR employing a range of concentrations. Percentage SEs were calculated based on the deviation of the concentration of the positive control from the actual concentration (SE: 5 %). The microbial community within a subset of samples was previously assessed by high-throughput sequencing of the 16S rRNA gene (Kaakoush et al., 2012) . Pearson correlation coefficients were calculated based on relative abundances of bacterial groups using GraphPad Prism version 5.0 (only for bacterial taxa present in .50 % of subjects). Informed consent was obtained from all children (or their parent/guardian for younger children) to be included in the study. This study was approved by the Research Ethics Committees of the University of New South Wales and the South East Sydney Area Health Service -Eastern Section, Sydney (03/163, 03/165 and 06/164).
No significant difference (P50.77) was observed in the prevalence of ZOT DNA between Crohn's disease patients (23/30, 76.7 %) and healthy controls (21/30, 70.0 %) (Tables 1 and 2 ). In relation to abundance, one Crohn's disease patient (CD2) had exceptionally high levels of ZOT relative to the mean (Table 1) , and thus was considered an outlier and removed from further analyses. Similar to the prevalence results, no significant difference in abundance of ZOT was identified between Crohn's disease patients and healthy controls (P50.70) (Tables 1   and 2 ). There was no significant difference in ZOT levels between male and female subjects (Crohn's disease: male, 2.4±1.0, female, 4.5±1.0, P50.16; healthy controls: male, 2.8±0.9, female, 2.9±1.1, P50.91). A trend showing an increase in ZOT abundance with age was observed for Crohn's disease patients (r50.30, P50.11), but not in the healthy controls. In contrast, a negative trend with age was previously observed for exotoxin 9 levels in Crohn's disease patients (r520.35, P50.069) (Kaakoush et al., 2014a) . However, differences in the mean ages of Crohn's disease patients and healthy controls may have contributed to these findings. Stratification of Crohn's disease patients in remission or with mild disease (,30) and moderate/severe disease (¢30) indicated that ZOT levels were higher in patients with moderate/severe disease (mild: 1.6±0.7; moderate/severe: 4.4±1.0; P50.059). A potential correlation of the abundance of ZOT with the Paediatric Crohn's Disease Activity Index (PCDAI) further supported this finding (r50.28, P50.13).
The levels of ZOT were then compared against the levels of C. concisus and exotoxin 9 in the same patients. Of particular interest, no correlation was found between the abundance of ZOT and C. concisus or ZOT and exotoxin 9 in Crohn's disease patients. In contrast, ZOT levels correlated with both C. concisus (r50.46, P50.007) and exotoxin 9 (r50.44, P50.01) levels in the healthy controls, even though C. concisus and exotoxin 9 levels did not correlate with each other (Kaakoush et al., 2014a) . Based on these and our previous findings, we hypothesize that AICC strains colonize Crohn's disease patients more efficiently than AToCC, thereby resulting in a lack of correlation between ZOT and C. concisus. This in turn points towards a greater role for AICC in Crohn's disease initiation, IP: 54.70.40.11
On: Sun, 13 Jan 2019 01:32:47 whilst AToCC may independently act as potential aggravators of disease (based on PCDAI results). In addition, based on our results, under normal conditions (healthy gut) both AICC and AToCC may be present, but at low levels.
ZOT levels also correlated with specific microbial taxa, including Faecalibacterium (r50.47, P50.02), Dialister (r50.60, P50.002), Adlercreutzia (r50.65, P50.0008) and Oscillospira (r50.55, P50.0065) out of a total 117 genera detected. The species (based on Pearson correlation coefficients) responsible for these correlations were Faecalibacterium prausnitzii, Dialister invisus, Adlercreutzia equolifaciens, Oscillospira guilliermondii and other unclassified Oscillospira spp. Given the short read length of the highthroughput sequencing data, species-level classification should be viewed as qualitative. Interestingly, exotoxin 9 levels were also found to correlate with the abundance of Dialister and Oscillospira (Kaakoush et al., 2014a) . Thus, the potential association between C. concisus and these taxa should be investigated further. The fact that A. equolifaciens, originally isolated from human faeces, can produce equol by metabolizing daidzeins (Maruo et al., 2008) and utilizes hydrogen within its cell metabolism (Takagaki et al., 2014) suggests that this correlation may relate to the affinity of both A. equolifaciens and C. concisus for hydrogen. F. prausnitzii was previously shown to be an antiinflammatory commensal bacterium within the human gut (Sokol et al., 2008) , although recent evidence paints a more complex role for this organism (Gerasimidis et al., 2014) . It is unclear why ZOT levels correlate with the abundance of F. prausnitzii, but these results reaffirm the importance of taxa belonging to the phylum Firmicutes in potentially providing a suitable niche for Campylobacter spp. within the gut (Bereswill et al., 2011; Kaakoush et al., 2014a, c). 
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In conclusion, whilst no significant difference in abundance of ZOT was identified between Crohn's disease patients and healthy controls, patients with moderate/severe Crohn's disease had higher levels of ZOT than those with mild Crohn's disease. However, these findings are not without limitations as differences in individual stool samples, particularly those arising from disorders with diarrhoea, may have contributed to the large variations seen within our results. Nevertheless, our findings suggest that AToCC, and particularly ZOT expression, should be investigated as potential aggravators but not initiators of Crohn's disease. However, this does not exclude the more complex scenario that some yet-tobe-identified strains have acquired the pathogenic mechanisms of both AICC and AToCC. To gain a better understanding of the role of C. concisus pathotypes in Crohn's disease, analysis of the levels of C.
concisus, exotoxin 9 and ZOT should be performed in faecal samples and intestinal biopsies of a larger cohort, and the functionality of C. concisus virulence factors that define the pathotypes assessed.
